Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Peptides|January 10, 2015
Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failureDamien Gruson, Sylvie A Ahn, Michel F RousseauBiochemia Medica|March 17, 2012
Biomarkers of inflammation and cardiac remodeling: the quest of relevant companions for the risk stratification of heart failure patients is still ongoingDamien Gruson, Sylvie A Ahn, Michel F RousseauJournal of Diabetes and Its Complications|September 4, 2019
Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F RousseauCardiovascular Diabetology|March 12, 2014
Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipidsMichel P Hermans, Sylvie A Ahn, Michel F RousseauJournal of Diabetes and Its Complications|December 21, 2013
Parental brevity linked to cardiometabolic risk in diabetic descendantsMichel P Hermans, Sylvie A Ahn, Michel F RousseauJournal of Diabetes and Its Complications|April 24, 2012
The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F RousseauDiabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F RousseauCardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F RousseauLipids in Health and Disease|October 11, 2012
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes femalesMichel P Hermans, Sylvie A Ahn, Michel F RousseauCardiovascular Diabetology|December 16, 2010
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes malesMichel P Hermans, Sylvie A Ahn, Michel F RousseauPageof 6